3592. Misbranding of P. F. Paula Fraser tablets.   U. S. v. 33-Cases   *    *    *.
(F.D.C. No. 31182.   Sample No. 21072-L.)
LIBEL FILED :    June 8,1951, Western District of Texas.
ALLEGED SHIPMENT : In the early part of 1950 and on or about April 25, 1951,
from Los Angeles, Calif.
PRODUCT : 33 cases, each containing 144 84-tablet vials, of P. F. Paula Fraser
tablets at San Antonio, Tex., in the possession of Howell & Rowell, Inc. Anal-
ysis showed that the product consisted essentially of aspirin and calcium
glutamate.
RESULTS OP INVESTIGATION : There were in possession of the consignee approxi-
mately 30,000 copies of a form letter which were printed locally and which
related to the product.
NATURE OF CHARGE: Misbranding, Section 502 (a), certain statements in the
form letter were false and misleading since the statements represented and
suggested that the article was an adequate and effective treatment for pain,
swelling, and rigidity of the joints, pains and aches in the muscles, arthritis,
neuritis, rheumatism, and lumbago, whereas it was not an adequate and
effective treatment for such conditions. The article was misbranded while
held for sale after shipment in interstate commerce.
DISPOSITION: September 8, 1951. Rowell & Rowell, Inc., claimant, having
consented to the entry of a decree, judgment of condemnation was entered
and the court ordered that the product be released under bond for relabeling,
under the supervision of the Federal Security Agency.